Beauty

Well-being

Business

Dermo-cosmetics: Pierre Fabre changes head of R&D

Pierre Fabre AudreyRicardCampion

The Pierre Fabre group has entrusted the management of its dermo-cosmetic research to Audrey Ricard Campion (formerly of L'Oréal), an engineer specializing in advanced formulation technologies. This appointment could strengthen the therapeutic and scientific approach of its flagship brands, from Ducray to Avène.

With this appointment, Pierre Fabre is sending a clear message: the future of cosmetics lies in science. On June 20, the pharmaceutical group officially announced the arrival of Audrey Ricard Campion as head of its Dermo-cosmetics & Personal Care R&D. A portfolio that carries a lot of weight: Avène, Ducray, Klorane, A-Derma, René Furterer, and more.

"His vision and ability to delve into every detail will be instrumental in achieving our medical mission: freeing patients from skin pathologies while helping them overcome the associated psychological and social aspects," said Frédéric Ennabli, CEO of Pierre Fabre Dermo-cosmétique, in a press release. 

Audrey Ricard Campion, a graduate engineer in physics and chemistry, isn't just a specialist in emulsions. Her expertise spans cutting-edge fields: encapsulation, vectorization, and adhesive polymers. Advanced formulation technologies that transform a classic treatment into a precision device.

A dermo-cosmetic for medical purposes

First, encapsulation: this involves protecting active ingredients, such as UV filters or moisturizing agents, in a micro-shell, in order to stabilize them, prevent their degradation, and release them at the right time. Vectorization is the art of targeting a specific area of ​​the skin—a follicle, a gland, or a specific layer of the epidermis—to maximize the effectiveness of the treatment. Finally, adhesive polymers are molecules capable of keeping an active ingredient on the skin longer by releasing it little by little.

These are areas in which Audrey Ricard Campion has made her mark, filing several patents, particularly in photoprotection and facial care. "This is an exceptional opportunity to lead research projects inspired by therapeutic advances and drug pathways, to offer innovative dermo-cosmetic treatments," she said in the press release. 

Based on the Oncopole campus in Toulouse, she leads a team of 420 people spread across three continents, including the innovation centers in Shanghai (China) and Rio de Janeiro (Brazil). In 2024, Pierre Fabre Laboratories generated revenue of €3,1 billion, 70% of which was generated internationally. 

READ ALSO: Pierre Fabre and Avène launch a solar aging simulator

Facebook
LinkedIn
WhatsApp
Email
In the same category

We use cookies